LYNN ARMAH: Open Payments
NPI 1841851672 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 11 payments from 4 companies in 2025. Trend: 2023 $515 · 2024 $691 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $275 |
| E.R. Squibb & Sons, L.L.C. | 3 | $138 |
| Alkermes, Inc. | 1 | $119 |
| Neurocrine BioSciences, Inc. | 4 | $74 |
Products named: INVEGA SUSTENNA, COBENFY, LYBALVI, INGREZZA.
Industry payments across OK — which companies pay providers there.
